Article

jdsupra.com on 2020-07-08 22:02

FDA Approves Mylan’s Biosimilar of HUMIRA (Adalimumab)

On July 6, 2020, the U.S. FDA approved Mylan’s aBLA for HULIO (adalimumab-fkjp), a biosimilar of AbbVie’s HUMIRA. HULIO is indicated for treating ...

Related news

FDA Approves Pfizer’s Adalimumab Biosimilar ABRILADA jdsupra.com
California , United States , Switzerland
PFDA approves Amgen biosimilar of AbbVie’s Humira pacbiztimes.com
Ventura
FDA Approves Amgen’s Biosimilar Version of Humira wsj.com
FDA Approves Ogivri, Mylan’s Biosimilar Version of Herceptin jdsupra.com
EC Approves Amgen’s Biosimilar Adalimumab jdsupra.com
United States
Recent Adalimumab Biosimilar Updates jdsupra.com
North America , Canada , Norway , Liechtenstein , Iceland
Sandoz Obtains FDA Approval for Adalimumab Biosimilar jdsupra.com
California , United States , Switzerland
Amgen’s Humira Biosimilar Becomes the Fourth FDA Approved Biosimilar jdsupra.com
United States
US FDA Issues CRL For Biocon and Mylan’s Pegfilgrastim Biosimilar jdsupra.com
DBoehringer Ingelheim settles litigation over Humira biosimilar dailyvoiceplus.com
Fairfield , West Chester , Ridgefield , Germany
Biosimilars Development Updates: Mylan’s Pipeline, Coherus’s Adalimumab aBLA, Amgen’s Eculizumab Biosimilar jdsupra.com
California , United States , Switzerland
Fresenius Kabi Announces FDA Approval of Adalimumab Biosimilar jdsupra.com
Canada
FDA Approves Third Biosimilar Product jdsupra.com
FDA: Amgen’s Biosimilar “Highly Similar” to Abbvie’s Humira jdsupra.com
BREAKING NEWS: FDA Expected to Approve Amgen’s Humira Biosimilar Today jdsupra.com
FDA Approves Pfizer’s EPO Biosimilar jdsupra.com
FDA Approves Another Interchangeable Biosimilar jdsupra.com
FDA Approves Sandoz’s Biosimilar Pegfilgrastim jdsupra.com
California , United States , Switzerland
FDA Approves Sandoz Filgrastim Biosimilar jdsupra.com
FDA Approves Boehringer Ingelheim’s Adalimumab Biosimilar jdsupra.com
Ingelheim am Rhein